In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.

The in vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) was compared with the activities of five other orally absorbable antimicrobial agents against 100 clinical isolates of Haemophilus influenzae. Roxithromycin MICs were generally twofold to fourfold higher than those of ery...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Jorgensen, J H, Redding, J S, Howell, A W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1986
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284180/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3488019/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.5.921
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!